person

Tadeusz D.

Country
Poland
Department
Niepubliczny Zakład Opieki Zdrowotnej ESCULAP Tadeusz Dereziński

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 20 partner sites.

Specializations

Resistant Hypertension

Focus on patients with uncontrolled blood pressure despite standard therapy.

  • Triple single‑pill combination therapy
  • Mineralocorticoid receptor antagonists
  • Loop diuretic comparison

Emphasis on improving control rates measured by Ambulatory Blood Pressure Monitoring.

Ambulatory Blood Pressure Monitoring

Utilization of 24‑hour blood pressure profiling to assess treatment efficacy.

  • 24‑hour mean systolic pressure
  • 24‑hour mean diastolic pressure
  • Threshold criteria for control

Supports precise classification of overpressure and Hypertension.

Cardiovascular Risk Reduction

Targeting reduction of systolic pressure to mitigate long‑term cardiovascular events.

  • Systolic blood pressure reduction magnitude
  • Comparative efficacy of eplerenone vs spironolactone
  • Comparative efficacy of torasemide vs spironolactone

Aligns with preventive cardiology objectives.

Pharmacologic Optimization in Hypertension

Evaluating therapeutic switches from ineffective regimens to optimized combinations.

  • Switching strategies
  • Triple SPC implementation
  • Tailored regimens for specific patient subgroups

Aims to enhance adherence and therapeutic outcomes.

Overpressure Management

Addressing elevated blood pressure readings above normal thresholds.

  • Definition of overpressure (SBP ≥125 mm Hg, DBP ≥80 mm Hg)
  • Early intervention protocols
  • Monitoring of uncontrolled cases

Integrates early detection with targeted pharmacotherapy.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.